Skip to Content

Month: November 2021

El Reino Unido autoriza el molnupiravir antiviral de Merck/Ridgeback Biotherapeutics para tratar el covid-19 leve a moderado

Mariana Toro (CNN) — La Agencia Reguladora de Medicamentos y Productos Sanitarios del Reino Unido dijo este jueves que había autorizado el antiviral oral de Merck y Ridgeback Biotherapeutics, el molnupiravir, para tratar casos de covid-19 de leves a moderados en adultos con riesgo de enfermedad grave. Es el primer antiviral oral del mundo autorizado

Continue Reading

North Carolina deputies ask for tips after dog found wandering the streets with mouth taped shut

By Kristy Kepley-Steward Click here for updates on this story     HENDERSON COUNTY, North Carolina (WLOS) — Henderson County deputies are asking for help finding information after a dog was found with its mouth taped in the Edneyville community. Authorities say on Wednesday, Oct. 27, the pup was found running around the Edneyville community, looking for

Continue Reading

‘Welcome to Nashville’ video goes viral

By Melanie Layden Click here for updates on this story     NASHVILLE, Tennessee (WSMV) — Austin Bever and Colin Cooper have made names for themselves in Music City as the comedic duo highlighting Nashville’s quirks in their now-viral music videos. Their videos depict all the different neighborhoods, restaurants, and tourist scenes in our booming city. “Welcome

Continue Reading

AstraZeneca pulls request for Swiss approval of COVID shot

BERLIN (AP) — AstraZeneca says it is withdrawing its application for approval of its COVID-19 vaccine in Switzerland because the country’s medical regulator wanted to restrict its use to people over age 50. Switzerland has cleared the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines, but the national medical regulator hadn’t yet granted AstraZeneca marketing authorization.

Continue Reading

AstraZeneca pulls request for Swiss approval of COVID shot

BERLIN (AP) — AstraZeneca says it is withdrawing its application for approval of its COVID-19 vaccine in Switzerland because the country’s medical regulator wanted to restrict its use to people over age 50. Switzerland has cleared the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines, but the national medical regulator hadn’t yet granted AstraZeneca marketing authorization.

Continue Reading
Skip to content